首页> 外文期刊>Japanese journal of infectious diseases >Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
【24h】

Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.

机译:在猿猴AIDS模型的慢性阶段,通过树突状细胞疫苗接种刺激病毒特异性T细胞应答。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Virus-specific CD8+ cytotoxic T lymphocyte (CTL) responses play an important role in the control of immunodeficiency virus infections. Therapeutic immunization with antigen-pulsed dendritic cells (DC) may be a promising strategy for stimulating CTL. However, decreases in DC number and function have been suggested in the host persistently infected with the virus, and this may constitute an obstacle to DC-based immunotherapy in the chronic phase. In this study, we show that virus-specific CTL responses were augmented by therapeutic immunization with inactivated virus-pulsed autologous DC in rhesus macaques that had maintained prophylactic vaccine-based control of virus replication for more than 3 years after simian or simian-human immunodeficiency virus challenge. Our results indicate the potential of DC in the chronic phase for efficiently stimulating CTL in vivo, suggesting the feasibility of therapeutic DC immunization for replenishing virus-specific CTL responses in the chronic phase after the prophylactic vaccine-based control of primary immunodeficiency virus infection.
机译:病毒特异性CD8 +细胞毒性T淋巴细胞(CTL)反应在控制免疫缺陷病毒感染中起重要作用。抗原脉冲树突状细胞(DC)的治疗性免疫可能是刺激CTL的有前途的策略。但是,已经表明持续感染该病毒的宿主体内DC数量和功能下降,这可能构成慢性期基于DC的免疫治疗的障碍。在这项研究中,我们表明,通过在猕猴或猿猴-人免疫缺陷后三年内保持基于疫苗的预防性疫苗复制的恒河猴的灭活病毒脉冲自体DC的治疗性免疫,可增强病毒特异性CTL反应病毒挑战。我们的结果表明,在慢性阶段DC可以有效地刺激体内CTL,这表明在预防性基于疫苗的原发性免疫缺陷病毒感染控制后,治疗性DC免疫在慢性阶段补充病毒特异性CTL反应的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号